STUB1 and neoplasm: Either of the techniques discussed above can be tumour informed, implying that the identification of genomic aberrations in ctDNA can be tailored based on sequencing of the tumour tissue in order to improve sensitivity and reduce the risk of false-positive results related to sequencing errors and also owing to non-tumour-related mutations such as those arising from CHIP.